Full Breakdown
Indian Tennis Player Parikshit Somani Receives Four-Year Doping Ban
By Drooid · · How we work
Core Event: Doping Violation and Sanction
Parikshit Somani, a 26-year-old Indian professional who reached a career-high ATP doubles ranking of No. 256 in July 2023, tested positive for the prohibited substance trimetazidine (TMZ) at an ATP Challenger event in Astana, Kazakhstan. The International Tennis Integrity Agency (ITIA) imposed a four-year period of ineligibility, effective from the independent tribunal’s decision, with credit for the provisional suspension already served. The ban runs until September 22, 2029.
Background & Context
Trimetazidine is a heart medication classified by the World Anti-Doping Agency (WADA) as a hormone and metabolic modulator, prohibited at all times. The substance has featured in high-profile anti-doping cases such as Russian figure skater Kamila Valieva and Chinese swimmer Sun Yang.
Timeline of Proceedings
| Date | Event |
|---|---|
| July 31 2025 | Somani provides a urine sample that later tests positive for trimetazidine. |
| August 29 2025 | WADA-accredited laboratory in Montreal reports an Adverse Analytical Finding, estimating TMZ concentration at 158.6 pg/mL. |
| September 23 2025 | ITIA issues a provisional suspension. |
| October 30 2025 | B-sample analysis confirms the A-sample finding. |
| January 29 2026 | ITIA formally charges Somani with an Anti-Doping Rule Violation. |
| February 20 2026 | Somani acknowledges the strict-liability nature of the violation but denies intentional use. |
| April 7 2026 | Somani requests a hearing before the Court of Arbitration for Sport; the case is referred to an independent tribunal. |
| May 11 2026 | His Honour Phillip Sycamore CBE is appointed chair; Professor Isla Mackenzie and Dr Abigail Gauci join as members. |
| August 19 2026 | Tribunal hearing held by remote videoconference; Somani presents a food-contamination defence. |
| September 22 2029 (scheduled) | Suspension is set to end. |
Data & Statistics
- Substance detected: Trimetazidine (TMZ)
- Concentration: 158.6 pg/mL (A-sample)
- Ban duration: Four years, with provisional suspension counted toward the total
Official Statements & Responses
The ITIA described Somani’s contamination theories as “scientifically implausible” and “unconvincing.” The Independent Tribunal found he had not proven how trimetazidine entered his system, so the standard four-year ineligibility under Article 10.2.1 of the Tennis Anti-Doping Programme was applied. All results from the Astana event and any earned up to September 23 2025 were disqualified, with forfeiture of titles, ranking points, prize money and appearance fees.
Why It Matters
The sanction reinforces tennis’s strict-liability anti-doping framework, where athletes are accountable for any prohibited substance regardless of intent. Somani’s case illustrates the difficulty of mitigating liability without concrete, scientifically supported evidence of inadvertent contamination. His removal from competition reduces India’s presence in the top-300 doubles rankings and impacts the emerging talent pipeline.
